Inducible nitric oxide synthase (iNOS): Role in asthma pathogenesis

Indian Journal of Biochemistry and Biophysics

Volumn 44, Issue 5, 2007, Pages 303-309

  Batra, Jyotsna ^a   Chatterjee, Rajshekhar ^a   Ghosh, Balaram ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Asthma; Gene; iNOS; Nitric oxide; NOS inhibitor

Indexed keywords

MAMMALIA;

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL; ASTHMA; BIOLOGICAL MODEL; ENZYMOLOGY; HUMAN; LUNG; METABOLISM; REVIEW;

ANIMALS; ASTHMA; HUMANS; LUNG; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84924279624     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. Frieri M (2005) Asthma concepts in the new millennium: update in asthma pathophysiology. Allergy Asthma Proc 26, 83-88
2. [No authors listed] (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351, 1225-1232
3. Jindal S K, Gupta D, Aggarwal A N, Jindal RC & Singh V (2000) Study of the prevalence of asthma in adults in North India using a standardized field questionnaire. J Asthma 37, 345-351
4. Chhabra S K, Gupta C K, Chhabra P & Rajpal S (1998) Prevalence of bronchial asthma in schoolchildren in Delhi. J Asthma 35, 291-296
5. Paramesh H (2002) Epidemiology of asthma in India. Indian J Pediatr 69, 309-312
6. Romanet-Manent S, Charpin D, Magnan A, Lanteaume A & Vervloet D (2002) Allergic vs nonallergic asthma: what makes the difference? Allergy 57, 607-613
7. Holgate S T (2002) Airway inflammation and remodeling in asthma: current concepts. Mol Biotechnol 22, 179-189
8. Renauld J C (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54, 577-589
9. Pavord I D and Tattersfield A E (1995) Bronchoprotective role for endogenous prostaglandin E2. Lancet 345, 436-438
10. Ricciardolo F L, Geppetti P, Mistretta A, Nadel J A, Sapienza M A, Bellofiore S & Di Maria G U (1996) Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 348, 374-377
11. Gerard C (2005) Biomedicine. Asthmatics breathe easier when it's SNO-ing. Science 308, 1560-1561
12. Que L G, Liu L, Yan Y, Whitehead G S, Gavett S H, Schwanz D A & Stamler J S (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308, 1618-1621
13. Taylor D A, McGrath J L, Orr L M, Barnes P J & O'Connor B J (1998) Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma. Thorax 53, 483-489
14. Payne D N, Adcock I M, Wilson N M, Oates T, Scallan M & Bush A (2001) Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 164, 1376-1381
15. Jatakanon A, Lim S, Kharitonov S A, Chung K F & Barnes P J (1998) Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53, 91-95
16. Jones S L, Kittelson J, Cowan J O, Flannery E M, Hancox R J, McLachlan C R & Taylor D R (2001) The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 164, 738-743
17. Palmer R M, Ferrige A G & Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526
18. Ignarro L J, Byrns R E, Buga G M & Wood K S (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologie and chemical properties identical to those of nitric oxide radical. Circ Res 61, 866-879
19. Dweik R A (2005) Nitric oxide, hypoxia, and Superoxide: the good, the bad, and the ugly! Thorax 60, 265-267
20. Nathan C & Xie Q W (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918
21. Crossin K L (1991) Nitric oxide (NO): a versatile second messenger in brain. Trends Biochem Sci 16, 81-82
22. Das I, Khan N S, Puri B K, Sooranna S R, de B J & Hirsch S R (1995) Elevated platelet calcium mobilization and nitricoxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun 212, 375-380
23. Cuzzocrea S (2006) Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 12, 3551-3570
24. Trachtman H (2004) Nitric oxide and glomerulonephritis. Semin Nephrol 24, 324-332
25. Raij L (2006) Nitric oxide in the pathogenesis of cardiac disease. J Clin Hypertens (Greenwich) 8, 30-39
26. Barnes P J & Belvisi M G (1993) Nitric oxide and lung disease. Thorax 48, 1034-1043
27. Iyengar R, Stuehr D J & Marietta M A (1987) Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci (USA) 84, 6369-6373
28. Bredt D S & Snyder S H (1989) Nitric oxide mediates glutamate-1 inked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci (USA) 86, 9030-9033
29. Gustafsson L E, Leone A M, Persson M G, Wiklund N P & Moncada S (1991) Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 181, 852-857
30. Salerno L, Sorrenti V, Di Giacomo C, Romeo G & Siracusa M A (2002) Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des 8, 177-200
31. Forstermann U, Schmidt H H, Pollock J S, Sheng H, Mitchell J A, Warner T D, Nakane M & Murad F (1991) Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42, 1849-1857
32. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6, 3051-3064
33. Meurs H, Maarsingh H & Zaagsma J (2003) Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 24, 450-455
34. Nathan C & Xie Q W (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269, 13725-13728
35. Nijkamp F P & Folkerts G (1994) Nitric oxide and bronchial reactivity. Clin Exp Allergy 24, 905-914
36. Gaston B, Singel D, Doctor A & Stamler J S (2006) S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 173, 1186-1193
37. Nagaki M, Shimura M N, Irokawa T, Sasaki T & Shirato K (1995) Nitric oxide regulation of glycoconjugate secretion from feline and human airways in vitro. Respir Physiol 102, 89-95
38. Barnes P J & Liew F Y (1995) Nitric oxide and asthmatic inflammation, Immunol Today 16, 128-130
39. Hibbs J B, Jr., Taintor R R, Vavrin Z & Rachlin E M (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157, 87-94
40. Guo H, Wei J & Kuo P C (2001) Nitric oxide inhibits expression of cytochrome B in endotoxin-stimulated murine macrophages. Biochem Biophys Res Commun 289, 993-997
41. Feder L S, Stelts D, Chapman R W, Manfra D, Crawley Y, Jones H, Minnicozzi M, Fernandez X, Paster T, Egan R W, Kreutner W & Kung T T (1997) Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 17, 436-442
42. Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M & Bertrand C (2000) Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 165, 1526-1533
43. Prado C M, Leick-Maldonado E A, Yano L, Leme A S, Capelozzi V L, Martins M A & Tiberio I F (2006) Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell Mol Biol 35, 457-465
44. Xiong Y, Karupiah G, Hogan S P, Foster P S & Ramsay A J (1999) Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 162, 445-452
45. De Sanctis G T, MacLean J A, Hamada K, Mehta S, Scott J A, Jiao A, Yandava C N, Kobzik L, Wolyniec W W, Fabian A J, Venugopal C S, Grasemann H, Huang P L & Drazen J M (1999) Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 189, 1621-1630
46. Keller A C, Rodriguez D & Russo M (2005) Nitric oxide paradox in asthma Mem Inst Oswaldo Cruz 100 Suppl 1, 19-23
47. Anonymous (1997) A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 15, 389-392
48. Dizier M H, Besse-Schmittler C, Guilloud-Bataille M, nnesi-Maesano I, Boussaha M, Bousquet J, Charpin D, Degioanni A, Gormand F, Grimfeld A, Hochez J, Hyne G, Lockhart A, Luillier-Lacombe M, Matran R, Meunier F, Neukirch F, Pacheco Y, Parent V, Paty E, Pin I, Pison C, Scheinmann P, Thobie N, Vervloet D, Kauffmann F, Feingold J, Lathrop M & Demenais F (2000) Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 162, 1812-1818
49. Xu W, Charles I G, Liu L, Moncada S & Emson P (1996) Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 219, 784-788
50. Burgner D, Rockett K, Ackerman H, Hull J, Usen S, Pinder M & Kwiatkowski D P (2003) Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes Immun 4, 506-514
51. Burgner D, Usen S, Rockett K, Jallow M, Ackerman H, Cervino A, Pinder M & Kwiatkowski D P (2003) Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum Genet 112, 379-386
52. Barcellos L F, Begovich A B, Reynolds R L, Caillier S J, Brassat D, Schmidt S, Grams S E, Walker K, Steiner L L, Cree B A, Stillman A, Lincoln R R, Pericak-Vance M A, Haines J L, Erlich H A, Hauser S L & Oksenberg J R (2004) Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 55, 793-800
53. Gonzalez-Gay M A, Llorca J, Sanchez E, Lopez-Nevot M A. Amoli M M, Garcia-Porrua C, Oilier W E & Martin J (2004) Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 43, 1182-1185
54. Konno S, Hizawa N, Yamaguchi E, Jinushi E & Nishimura M (2001) (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy. J Allergy Clin Immunol 108, 810-814
55. Gao P S, Kawada H, Kasamatsu T, Mao X Q, Roberts M H. Miyamoto Y, Yoshimura M, Saitoh Y, Yasue H, Nakao K. Adra C N, Kun J F, Moro-oka S, Inoko H, Ho L P, Shirakawa T & Hopkin J M (2000) Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun 267, 761-763
56. Leung T F, Liu E K, Li C Y, Chan I H, Yung E, Lam C W & Wong G W (2006) Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration. Pediatr Pulmonol 41, 649-655
57. Holla L I, Stejskalova A, Znojil V & Vasku A (2006) Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases. Clin Exp Allergy 36, 1592-1601
58. Batra J, Pratap S T, Mabalirajan U, Sinha A, Prasad R & Ghosh B (2007) Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax 62, 16-22
59. Prado C M, Leick-Maldonado E A, Yano L, Leme A S. Capelozzi V L, Martins M A & Tiberio I F (2006) Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell Mol Biol 35, 457-465
60. Ricciardolo F L, Nijkamp F P & Folkerts G. (2006) Nitric-oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets 7, 721-735